Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Industry Updates

Barclay CTA Index down 0.53% in February; currency traders gain from stronger US Dollar (+0.77% YTD)

Wednesday, March 13, 2013
Opalesque Industry Update: Managed futures lost 0.53% in February according to the Barclay CTA Index compiled by BarclayHedge. The Index remains up 0.77% year to date.

“A combination of trend reversals and downdrafts across the major futures markets made the task of extracting profits more difficult in February,” says Sol Waksman, founder and president of BarclayHedge.

Four of Barclay’s eight CTA indices had negative returns in February, while four indices gained ground. The Diversified Traders Index was down 0.93%, Systematic Traders lost 0.69%, and the Financial & Metal Traders Index slid 0.07%.

“Commodity markets were down, interest rates reversed trend toward the end of the month, and equity trading required getting the country and the direction right in order to come out ahead,” says Waksman.

The Currency Traders Index gained 0.51% in February, Discretionary Traders added 0.11%, and Agricultural Traders were up 0.10%.

“Currency traders had the benefit of the wind to their backs from a rising US Dollar as a gridlocked election in Italy weakened the EUR and concerns over further easing by The Bank of England triggered selling in the GBP,” says Waksman.

The Barclay BTOP50 Index, which measures performance of the largest CTAs, gained 0.18% in February.

All eight CTA strategies monitored by BarclayHedge are in positive territory thus far in 2013. After two months, Diversified Traders are up 1.00%, Currency Traders have gained 0.98%, and Agricultural Traders have added 0.93%.

BarclayHedge

Press Release

BM

What do you think?

   Use "anonymous" as my name    |   Alert me via email on new comments   |   
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its